ANALYSIS OF DOSE INTENSITY FOR ADJUVANT CHEMOTHERAPY TRIALS IN STAGE-II BREAST-CANCER

被引：424

作者：

HRYNIUK, W ^{[1
]}

LEVINE, MN ^{[1
]}

机构：

[1] MCMASTER UNIV, HAMILTON L8S 4L8, ONTARIO, CANADA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 08期

关键词：

D O I：

10.1200/JCO.1986.4.8.1162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1162 / 1170

页数：9

共 53 条

[1]

BONADONNA G, 1983, CANCER TREAT REP, V67, P527

[2] DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER [J].

BONADONNA, G ;

VALAGUSSA, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) :10-15

[3]

BONADONNA G, BREAST CANCER RES TR

[4] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE OR CMF IN PREMENOPAUSAL WOMEN WITH STAGE-II BREAST-CANCER [J].

BRINCKER, H ;

MOURIDSEN, HT ;

ANDERSEN, KW .

BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (01) :91-95

[5] PROSPECTIVE RANDOMIZED TRIAL OF ONE-HOUR SEQUENTIAL VERSUS SIMULTANEOUS METHOTREXATE PLUS 5-FLUOROURACIL IN ADVANCED AND RECURRENT SQUAMOUS-CELL HEAD AND NECK-CANCER [J].

BROWMAN, GP ;

ARCHIBALD, SD ;

YOUNG, JEM ;

HRYNIUK, WM ;

RUSSELL, R ;

KIEHL, K ;

LEVINE, MN .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) :787-792

[6]

BUDMAN D, 1985, COMMUNICATION 0909

[7]

CARDE P, 1981, P AM ASSOC CANC RES, V22, P512

[8]

CARTER SK, 1972, CANCER-AM CANCER SOC, V30, P1543, DOI 10.1002/1097-0142(197212)30:6<1543::AID-CNCR2820300621>3.0.CO

[9]

2-V

[10] COMBINATION THERAPY WITH METHOTREXATE AND 5-FLUOROURACIL - A PROSPECTIVE RANDOMIZED CLINICAL-TRIAL OF ORDER OF ADMINISTRATION [J].

COATESAS ;

TATTERSALL, MHN ;

SWANSON, C ;

HEDLEY, D ;

FOX, RM ;

RAGHAVAN, D .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) :756-761

← 1 2 3 4 5 6 →